Skip to main content

Table 5 Estimates of anti-HCV prevalence by population and by country

From: Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update

Country Included references Selected references Sample size Anti-HCV prevalence (%) (95% CI) Baseline sample size Baseline prevalence (%) (95% CI)
General population
 Spain 3 Single low risk 13678 0.8 (0.65–0.95) [20] 364 1.1(0.3–2.8) [17]
 Italy 2 Pooled low risk 12444 1.37 (1.17–1.58) [22, 23] 4826 5.9(5.2–6.6) [17]
 Poland 2 Single high risk 61805 1.5 (1.4–1.6) [24] – –
 Czech Republic 1 Single low risk 3000 1.67 (1.21–2.13) [27] – –
 Portugal 1 Single low risk 1627 0.54 (0.18–0.9) [28] – –
 Netherlands 1 Single high risk 6036 0.56 (0.37–0.75) [33] 4046 0.1(0.0–0.2) [17]
 Ireland 1 Single low risk 3795 0.98 (0.67–1.29) [26] 1478 0.1(0.0–0.4) [17]
Pregnant women
 UK 2 Single low risk 31467 0.1 (0.06–0.13) [31] 110621 1 [17]
 Slovenia 1 Single low risk 31849 0.13 (0.09–0.17) [32] 90 4.4 [17]
 Italy 1 Single high risk 5184 0.2 (0.08–0.32) [33] 10881 1.7 (1.4–1.9) [17]
 Poland 1 Single low risk 38309 0.76 (0.67–0.85) [34] 1534 0.1 (0.0–0.3) [17]
 Sweden 1 Single low risk 4112 0.27 (0.11–0.43) [35] – –
 Spain 1 Single low risk 21379 0.55 (0.45–0.65) [36] – –
First-time blood donors
 Italy 1 Single low risk 1934612 0.09 (0.08–0.09) [37] – 0.094 (0.085–0.104) [17]
 Greece 1 Single high risk 3838919 0.03 (0.03–0.03) [38] – 1.202 (1.114–1.295) [17]
MSM
 Netherlands 1 Single high risk 439 7.1 (4.69–9.51) [40] – –
 UK 1 Single low risk 1140 1.8 (1.03–2.57) [39] – –
 France 1 Single low risk 13051 5.1 (4.72–5.48) [41] – –
Prisoner
 UK 2 Pooled high risk 1484 7.9 (6.53–9.28) [42, 43] 5450 17.7(16.4–18.4) [18]
 Portugal 2 Pooled high risk 82 16.51 (8.42–24.6) [44, 45] 151 34.4(26.9–42.6) [18]
 Norway 1 Single high risk 62 51.6 (39.06–64.14) [63]   
 Spain 1 Single high risk 436 16 (12.55–19.45) [47] – 22.7(18.3–27.1) [18]
PWID
 UK 3 Pooled low risk 1818 36.5 (34.29–38.72) [48,49,50] 3144 49.1 (47.4–50.9) [18]
 France 2 Pooled low risk 3015 57.26 (55.49–59.02) [53, 54] – –
 Spain 2 Single low risk 754 72 (68.79–75.21) [52] – –
 Greece 2 Pooled high risk 3099 69.67 (68.05–71.29) [55, 56] 1309 68.1 (65.5–70.6) [18]
Germany 1 Pooled low risk from a single study 1526 66.18 (63.8–68.55) [57] – –
 Italy 1 Single high risk 261 47.1 (41.03–53.17) [64] 743 60.5 (56.8–64.0) [18]
 Hungary 1 Single low risk 755 48.24 (44.67–51.81) [58] 652 24.1 (20.8–27.6) [18]
 Croatia 1 Pooled low risk from a single study 830 34.04 (30.81–37.26) [59] 200 44 (37.0–51.2) [18]
 Sweden 1 Single high risk 1386 82 (79.98–84.02) [60] – –
 Ireland 1 Single high risk 228 63.6 (57.34–69.86) [61] 200 41.5 (34.6–48.7) [18]
 Bosnia and Herzegovina 1 Single high risk 120 52.5 (43.53–61.47) [62] – –
 Norway 1 Single high risk 304 41 (35.46–46.54) [63] 6342 63.0 (61.8–64.2)
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us